Kymera Therapeutics Inc (KYMR)

01:37 AM

Kymera Therapeutics Q2 2025: Unpacking Contradictions in Clinical Expectations, Safety Monitoring, and Dosing Strategies - AInvest

01:37 AM

01:35 AM

Kymera Therapeutics: Strategic Catalysts and Monetization Potential in a High-Stakes Biotech Landscape - AInvest

01:35 AM

01:09 AM

Kymera Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat

01:09 AM

10:20 AM

Transcript : Kymera Therapeutics, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener

10:20 AM

09:45 AM

Kymera Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

09:45 AM

09:42 AM

Earnings call transcript: Kymera Therapeutics Q2 2025 results miss forecasts By Investing.com - Investing.com UK

09:42 AM

09:10 AM

Kymera Q2 2025 slides: Strong pipeline advances despite revenue decline By Investing.com - Investing.com Australia

09:10 AM

09:05 AM

Kymera Q2 2025 slides: Strong pipeline advances despite revenue decline - Investing.com

09:05 AM

08:10 AM

Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

08:10 AM

07:28 AM

Kymera Revenue Drops 55 Percent in Q2 - The Motley Fool

07:28 AM

07:26 AM

Kymera’s Losses Widen But Wall Street Stays Optimistic - Finimize

07:26 AM

07:23 AM

Kymera Therapeutics, Inc. SEC 10-Q Report - TradingView

07:23 AM

07:22 AM

Kymera Therapeutics' Q2 2025 Earnings Miss: A Test of Resilience in the TPD Space? - AInvest

07:22 AM

07:22 AM

Kymera Therapeutics Q2 Loss Widens, Collaboration Revenue Falls - MarketScreener

07:22 AM

07:10 AM

Earnings Flash (KYMR) Kymera Therapeutics, Inc. Reports Q2 Revenue $11.5M, vs. FactSet Est of $22.2M - MarketScreener

07:10 AM

07:09 AM

Earnings Flash (KYMR) Kymera Posts Q2 Loss $0.95 a Share, vs. FactSet Est of $0.89 Loss - MarketScreener

07:09 AM

07:07 AM

Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update - The Manila Times

07:07 AM

07:07 AM

Kymera Therapeutics Q2 revenue misses expectations, net loss widens - TradingView

07:07 AM

07:00 AM

Kymera Reports Phase 1 Success, Secures $750M Gilead Partnership with $1B Cash Position | KYMR Stock News - Stock Titan

07:00 AM

Aug 10, 2025

Gilead Sciences Signs $750M Deal For Cancer Drug With Kymera Therapeutics, Predicts Hit To Its Annual Profit - MSN

Aug 10, 2025

Aug 09, 2025

Kymera Therapeutics Earnings Preview: What to Expect - AInvest

Aug 09, 2025

Aug 08, 2025

Kymera Therapeutics KYMR Q2 2025 Earnings Preview Upside Potential Driven by Strategic Partnerships - AInvest

Aug 08, 2025

Aug 08, 2025

Earnings To Watch: Kymera Therapeutics Inc (KYMR) Reports Q2 2025 Result - Yahoo Finance

Aug 08, 2025

Aug 07, 2025

Kymera Therapeutics Becomes Oversold (KYMR) - Nasdaq

Aug 07, 2025

Aug 05, 2025

Earnings Preview: KYMR to Report Financial Results Pre-market on August 11 - 富途牛牛

Aug 05, 2025

Aug 04, 2025

Kymera Therapeutics to Report Second Quarter 2025 Financial Results on August 11, 2025 - The Manila Times

Aug 04, 2025

Aug 04, 2025

Kymera Therapeutics reports Q2 2025 results, plans call on August 11. - AInvest

Aug 04, 2025

Aug 04, 2025

Clinical-Stage Biotech Kymera Therapeutics Sets Q2 Earnings Date: Key Updates Expected on Immunology Pipeline - Stock Titan

Aug 04, 2025

Aug 03, 2025

Is Kymera Therapeutics Inc. a growth stock or a value stockFree Investment Community - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Kymera Therapeutics Inc. generate profit in a changing economyTransform your portfolio with high-yield stocks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Kymera Therapeutics Inc. stock higher in 2025Get expert analysis on top stock picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Kymera Therapeutics Inc. stock price move sharplyAchieve consistent profits with proven methods - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Kymera Therapeutics Inc. stock in 2025Dynamic portfolio growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate Kymera Therapeutics Inc. as a “Buy”Stay ahead with daily market updates - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Why is Kymera Therapeutics Inc. stock attracting strong analyst attentionUnlock powerful trading tools for investors - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is Kymera Therapeutics Inc. company’s growth strategyExplosive earning power - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What analysts say about Kymera Therapeutics Inc. stockCapitalize on emerging trends for profits - Jammu Links News

Aug 02, 2025

Aug 01, 2025

How strong is Kymera Therapeutics Inc. company’s balance sheetSwing Trade Review With Proven Results - Jammu Links News

Aug 01, 2025

Aug 01, 2025

Kymera Therapeutics: A Biotech Company with a Promising Future - AInvest

Aug 01, 2025

Aug 01, 2025

Is it the right time to buy Kymera Therapeutics Inc. stockBreakout Stocks Ideas For 2025 - Jammu Links News

Aug 01, 2025

Jul 31, 2025

Gilead, Kymera Partner in $750M Deal to Develop Novel Molecular Glue Degraders for Cancer - MSN

Jul 31, 2025

Jul 30, 2025

Kymera Therapeutics Inc. Chart Enters High Volatility ZoneSecure Return Focused Investment Plan Released - metal.it

Jul 30, 2025

Jul 30, 2025

Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance

Jul 30, 2025

Jul 29, 2025

Published on: 2025-07-29 17:18:26 - metal.it

Jul 29, 2025

Jul 29, 2025

How did KYMR's Q1 2025 EPS forecast compare to past trends? - AInvest

Jul 29, 2025

Jul 28, 2025

What analysts say about Kymera Therapeutics Inc. stock outlookMarket Surge Signal for Swing Traders Triggered - metal.it

Jul 28, 2025

Jul 28, 2025

How volatile is Kymera Therapeutics Inc. stock compared to the marketAchieve breakthrough results with expert guidance - Jammu Links News

Jul 28, 2025

Jul 28, 2025

What are Kymera Therapeutics Inc. company’s key revenue driversFast-track wealth growth - Jammu Links News

Jul 28, 2025

Jul 27, 2025

Does Kymera Therapeutics Inc. stock perform well during market downturnsUnlock your trading potential today - Jammu Links News

Jul 27, 2025